Search alternatives:
progress » process (Expand Search)
Showing 2,901 - 2,920 results of 12,642 for search 'detection (progress OR programs)', query time: 0.22s Refine Results
  1. 2901
  2. 2902
  3. 2903

    A Survey on Event Tracking in Social Media Data Streams by Zixuan Han, Leilei Shi, Lu Liu, Liang Jiang, Jiawei Fang, Fanyuan Lin, Jinjuan Zhang, John Panneerselvam, Nick Antonopoulos

    Published 2024-03-01
    “…Moreover, as deep learning techniques continue to advance and make important breakthroughs in various fields, researchers are using this technology to progressively optimize the effectiveness of Event Detection (ED) and tracking algorithms. …”
    Get full text
    Article
  4. 2904

    Traffic Impact Assessment System using Yolov5 and ByteTrack by Jin Jie Ng, Kah Ong Michael Goh, Connie Tee

    Published 2023-09-01
    “…The most useful metrics are frequently those that support the program's ability to fulfil business requirements. …”
    Get full text
    Article
  5. 2905
  6. 2906

    Design and Development of a Public AI Referee Assistance System Based on Harmony OS Platform by Jingjing Zhao, Chang Zhu, Bo Leng, Jiantao Qi

    Published 2025-03-01
    “…The AI referee assistance system uses the Harmony OS platform to build a frontend mini-program and uses the YOLOV5 algorithm to detect and track corresponding targets, ultimately achieving judgments both inside and outside the bounds as well as serving violations. …”
    Get full text
    Article
  7. 2907

    Few-Shot Learning With Prototypical Networks for Improved Memory Forensics by Muhammad Fahad Malik, Ammara Gul, Ayesha Saadia, Faeiz M. Alserhani

    Published 2025-01-01
    “…This research introduces a novel approach for malware detection using memory forensics and prototypical networks. …”
    Get full text
    Article
  8. 2908

    Hybridization Chain Reaction-Enhanced Ultrasensitive Electrochemical Analysis of miRNAs with a Silver Nano-Reporter on a Gold Nanostructured Electrode Array by Bin Wang, Huiqiang Ma, Mingxing Zhou, Xian Huang, Ying Gan, Hong Yang

    Published 2025-03-01
    “…Abnormal expression of miRNAs is associated with the occurrence and progression of cancer and other diseases, making miRNAs essential biomarkers for disease diagnosis and prognosis. …”
    Get full text
    Article
  9. 2909

    GAMMA-SPECTROMETER FOR WATER AREAS AND BOTTOM SEDIMENTS RADIATION MONITORING by A. I. Zhukouski, A. Anshakou, A. Biryla, U. Chyrykala, Y. Kanavalau, A. O. Nichyparchuk, A. Savitski, A. A. Khrutchinsky, S. A. Kutsen

    Published 2016-12-01
    “…The aim of theoretical research was to optimize detection device construction, estimate spectrometer metrological parameters in given measurement geometries, and determine effective position of detection device in the process of in situ measurements. …”
    Get full text
    Article
  10. 2910
  11. 2911

    Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non... by Katsuyuki Hotta, Yuka Kato, Natasha Leighl, Nagio Takigawa, Rabab Mohamed Gaafar, Hiroe Kayatani, Taizo Hirata, Kadoaki Ohashi, Toshio Kubo, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura

    Published 2015-01-01
    “…Although trials enrolling molecularly selected patients and all-comer trials had similar OS-hazard ratios (OS-HRs) (0.99 vs. 1.04), the former exhibited greater progression-free survival-hazard ratios (PFS-HR) (mean, 0.40 vs. 1.01; P<0.01). …”
    Get full text
    Article
  12. 2912

    Validation of the Brugia Test Plus to detect IgG4 antibodies in individuals from Belitung Timur, a Brugia malayi endemic area in Indonesia. by Taniawati Supali, Elisa Iskandar, Noviani Sugianto, Yenny Djuardi, Katherine Gass, Jean M Saunders, Peter U Fischer, Marco A Biamonte

    Published 2025-08-01
    “…This study has demonstrated that the novel BT+ is feasible for teams to implement and achieves good sensitivity, making it well suited for monitoring and evaluating the progress of the brugian- filariasis elimination program.…”
    Get full text
    Article
  13. 2913

    Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay by Julia Faillace Thiesen, Elise Jacquemet, Pascal Campagne, Denis Chatelain, Etienne Brochot, Yves-Edouard Herpe, Nolwenn M. Dheilly, Fabrice Bouilloux, Bénédicte Rognon, Alexandre Douablin, Guillaume Leboucher, Florent Percher, Marc Eloit, Philippe Pérot

    Published 2025-05-01
    “…Abstract Background Cervical cancer screening programs are increasingly relying on sensitive molecular approaches as primary tests to detect high-risk human papillomaviruses (hrHPV), the causative agents of cervix cancer. …”
    Get full text
    Article
  14. 2914

    Assessment of Fraud Deterrence and Detection Procedures Used in a Web-Based Survey Study With Adult Black Cisgender Women: Description of Lessons Learned and Recommendations by Amber I Sophus, Jason W Mitchell

    Published 2025-03-01
    “…The final enrolled sample in this online study consisted of 155 respondents who provided consent, were deemed eligible, and passed fraud deterrence features and fraud detection benchmarks. In this paper, we discuss the lessons learned and provide recommendations for leveraging available features in survey software programs to help deter bots and enhance fraud detection procedures beyond relying on survey software options. …”
    Get full text
    Article
  15. 2915

    Compound heterozygosity of a De novo 16q24.1 deletion and missense mutation in COX4I1 leads to developmental regression, intellectual disability, and seizures by Zhen Liu, Mei He, Xuan Luo, Hu Pan, Xiao Mao, Jinping Su

    Published 2025-06-01
    “…Compound heterozygosity for a de novo 16q24.1 deletion and a P152T missense mutation in the COX4I1 was detected. Additionally, we provide the first instance of progressive brain atrophy observed through MRI in a COX4I1 deficiency patient, broadening our understanding of the mutation spectrum and clinical phenotype of this genetic disorder.…”
    Get full text
    Article
  16. 2916

    Clinical utility of CSF Aβ38 in Japanese research and clinical cohorts by Tamao Tsukie, Kensaku Kasuga, Masataka Kikuchi, Takanobu Ishiguro, Akinori Miyashita, Osamu Onodera, Takeshi Iwatsubo, Japanese Alzheimer's Disease Neuroimaging Initiative, Takeshi Ikeuchi

    Published 2025-04-01
    “…CSF Aβ38 and Aβ40 were prominently decreased in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus.…”
    Get full text
    Article
  17. 2917

    Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer's disease dementiaResearch in context by Sinead Gaubert, Pilar Garces, Jörg Hipp, Ricardo Bruña, Maria Eugenia Lopéz, Fernando Maestu, Delshad Vaghari, Richard Henson, Claire Paquet, Denis-Alexander Engemann

    Published 2025-04-01
    “…Summary: Background: Developing non-invasive and affordable biomarkers to detect Alzheimer's disease (AD) at a prodromal stage is essential, particularly in the context of new disease-modifying therapies. …”
    Get full text
    Article
  18. 2918

    Isolated Central Nervous System Infiltrated and Progressed to Acute Myeloid Leukemia from Chronic Myeloid Leukemia with e1a3 BCR-ABL1 Transcript: A Rare Case Report and Literature... by Qiang X, Wen Q, Li J, Chen S, Tao T, Zhang H, Wang P, Peng X, Feng Y, Zhang X

    Published 2025-01-01
    “…Subsequent bone marrow analysis and flow cytometry detection of cerebrospinal fluid indicated that the patient had entered the blast phase, progressing to acute myeloid leukemia (AML). …”
    Get full text
    Article
  19. 2919

    Peripheral TNF-&amp;alpha; and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy by Wu J, Ou X, Yuan K, Shi F, Zhou Q, Lyu S, Li Y, Zhao Y, Cao Y, Sun J, Song Q

    Published 2025-07-01
    “…Jiangping Wu,1,&amp;ast; Xin Ou,1,&amp;ast; Keyu Yuan,2 Feng Shi,3 Quan Zhou,4 Suzhen Lyu,2 Yanping Li,2 Yanjie Zhao,5 Yu Cao,1 Jianping Sun,1 Qingkun Song1,6 1Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China; 2Department of Breast Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 3Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 4Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, People’s Republic of China; 5Department of Medical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China; 6Department of Clinical Epidemiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People’s Republic of China&amp;ast;These authors contributed equally to this workCorrespondence: Qingkun Song, Center of Clinical Epidemiology and Biobank, Beijing Youan Hospital, Capital Medical University, Xitoutiao 8, Fengtai District, Beijing, 100069, People’s Republic of China, Tel +86-10-83997462, Email songqingkun@ccmu.edu.cnBackground: Programmed death-ligand 1 (PD-L1) is an immunotherapy target; however, its detection is based on biopsy tissues, and repeated biopsies present clinical challenges. …”
    Get full text
    Article
  20. 2920